Dimensional Fund Advisors
ORIC icon

Dimensional Fund Advisors’s Oric Pharmaceuticals ORIC Stock Holding History

Dimensional Fund Advisors’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25.6M Buy
1,900,144
+98,745
+5% +$1.23M ﹤0.01% 1893
2026
Q2 		$19.5M Buy
1,801,399
+330,109
+22% +$2.99M ﹤0.01% 2049
2026
Q1 		$18.6M Buy
1,471,290
+244,060
+20% +$2.77M ﹤0.01% 2008
2025
Q4 		$10M Buy
1,227,230
+433,359
+55% +$4.99M ﹤0.01% 2282
2025
Q3 		$9.5M Buy
793,871
+79,005
+11% +$831K ﹤0.01% 2320
2025
Q2 		$7.26M Sell
714,866
-12,964
-2% -$87K ﹤0.01% 2407
2025
Q1 		$4.06M Buy
727,830
+10,642
+1% +$93.1K ﹤0.01% 2555
2024
Q4 		$5.79M Buy
717,188
+103,237
+17% +$947K ﹤0.01% 2494
2024
Q3 		$6.29M Buy
613,951
+147,289
+32% +$1.46M ﹤0.01% 2454
2024
Q2 		$3.3M Buy
466,662
+305,860
+190% +$2.74M ﹤0.01% 2620
2024
Q1 		$2.21M Buy
160,802
+136,126
+552% +$1.62M ﹤0.01% 2771
2023
Q4 		$227K Sell
24,676
-16
-0.1% -$116 ﹤0.01% 3178
2023
Q3 		$149K Buy
24,692
+16
+0.1% +$131 ﹤0.01% 3259
2023
Q2 		$191K Buy
24,676
+14,632
+146% +$83.1K ﹤0.01% 3243
2023
Q1 		$57.3K Buy
+10,044
New +$52.5K ﹤0.01% 3372

Other funds holding ORIC

Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

Dimensional Fund Advisors's ORIC Position: Q3 2026 in Review

Dimensional Fund Advisors increased its Oric Pharmaceuticals (ORIC) stake by 5.5% in Q3 2026, buying an estimated $1.23M and bringing the position to 1,900,144 shares worth $25.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1893.

Dimensional Fund Advisors first reported a position in ORIC in Q1 2023 and has held it in 15 quarters since. 35 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

  • Dimensional Fund Advisors held 1,900,144 shares of Oric Pharmaceuticals worth $25.6M as of Q3 2026.
  • Dimensional Fund Advisors bought 98,745 Oric Pharmaceuticals shares in Q3 2026, an estimated $1.23M.
  • Oric Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #1893 holding.
  • Dimensional Fund Advisors first reported a position in Oric Pharmaceuticals in Q1 2023 and has held it in 15 quarters since.
  • 35 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.